Positive Endomyocardial Biopsy in Cardiac Sarcoidosis: Predictors and Outcomes From the Japanese ILLUMINATE-CS (Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis) Registry
Journal of Cardiac Failure · 2026
DOI: 10.1016/j.cardfail.2026.02.025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiac Failure, 2026. Verfasst von Daichi Maeda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cardiology, Osaka Med…. Hauptthemen laut MEDLINE: Cardiomyopathies, Disease Management, Myocardium, Registries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Novartis, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
BACKGROUND: Cardiac sarcoidosis (CS) increases the risk of heart failure and fatal arrhythmias. Although endomyocardial biopsy (EMB) provides a specific diagnosis, its sensitivity is limited, and predictors of positivity remain unclear. Most evidence derives from a single Finnish cohort, with limited confirmation in independent cohorts. This study aimed to investigate clinical features and predictors of EMB positivity using a large-scale Japanese CS registry. METHODS: This subanalysis of the Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis (ILLUMINATE-CS) study included patients who underwent EMB at diagnosis. Two components were assessed: (1) the association between Myocardial Inflammatory Diseases in Finland (MIDFIN)-derived predictors (ventricular tachycardia/fibrillation, left ventricular ejection fraction ≤45%, elevated cardiac troponins, and late gadolinium enhancement in the mid- or apical septal segments) and EMB positivity, and (2) the identification of predictors within the ILLUMINATE-CS cohort. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmic events. RESULTS: Of 246 patients (aged 61.0 ± 11.3 years; 42.3% male), 55 (22.2%) had a positive EMB result. MIDFIN-derived predictors showed a directionally consistent association with EMB positivity in the ILLUMINATE-CS cohort (n = 39, P for trend = .042). In the ILLUMINATE-CS cohort, independent predictors for EMB positivity included thicker basal interventricular septum, a greater number of positive segments on 18F-fluorodeoxyglucose positron emission tomography scan, and greater B-type natriuretic peptide levels, with optimal cutoffs of 8.9 mm, 10 segments, and 155.0 pg/mL, respectively. EMB positivity increased with the number of criteria met (n = 100, P for trend < .001). The composite endpoint did not differ between EMB-positive and negative groups. CONCLUSIONS: MIDFIN-derived predictors showed a directionally consistent association with EMB positivity in the Japanese cohort. International studies are warranted to optimize EMB use and improve CS diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
- Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine, Suita, Japan.
Förderung
- Japan Society for the Promotion of Science
- Novartis
- Japan Agency for Medical Research and Development
Zitieren
APA
Maeda, D., Fujimoto, Y., Nabeta, T., Kitai, T., Naruse, Y., Taniguchi, T., Tanaka, H., Morimoto, R., Baba, Y., Yoshioka, K., & Matsue, Y. (2026). Positive Endomyocardial Biopsy in Cardiac Sarcoidosis: Predictors and Outcomes From the Japanese ILLUMINATE-CS (Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis) Registry. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.02.025
Vancouver
Maeda D, Fujimoto Y, Nabeta T, Kitai T, Naruse Y, Taniguchi T, et al. Positive Endomyocardial Biopsy in Cardiac Sarcoidosis: Predictors and Outcomes From the Japanese ILLUMINATE-CS (Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis) Registry. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2026.02.025
BibTeX
@article{Maeda2026,
author = {Maeda, Daichi and Fujimoto, Yudai and Nabeta, Takeru and Kitai, Takeshi and Naruse, Yoshihisa and Taniguchi, Tatsunori and Tanaka, Hidekazu and Morimoto, Ryota and Baba, Yuichi and Yoshioka, Kenji and Matsue, Yuya},
title = {Positive Endomyocardial Biopsy in Cardiac Sarcoidosis: Predictors and Outcomes From the Japanese ILLUMINATE-CS (Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis) Registry},
journal = {Journal of Cardiac Failure},
year = {2026},
doi = {10.1016/j.cardfail.2026.02.025}
}
EUVIMED